Inagene launches GLP-1 Insights Program combining genetic insights with registered dietitian support to help Canadians understand their genetic response to weight management and diabetes medications
New research suggest genetics may help explain why individual response to weight management and diabetes medications can vary TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) — Inagene Diagnostics has launched a new product giving Canadians access to emerging research on how genetics may influence response to GLP-1 medications. Medications such as Ozempic, Wegovy, Mounjaro and Zepbound […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
